Placental Infarction and Thrombophilia
Authors:
- Melissa WalkerMWMelissa Walker
- Julie RobertsonJRJulie Robertson
- Brendan FitzgeraldBFBrendan Fitzgerald
- Sarah KeatingSKSarah Keating
- Anne McLeodAMAnne McLeod
- John C. P. KingdomJKJohn C. P. Kingdom
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 117 (4) , 929-934
Abstract
To estimate the relative importance of positive maternal thrombophilia testing compared with additional pathological evidence of abnormal placentation with placental infarction. We performed a retrospective cohort study over a 10-year period in 180 singleton high-risk pregnancies (delivery at 22-34 6/7 weeks of gestation) that had histologic evidence of placental infarction. The rate of positive maternal tests for antiphospholipid syndrome, factor V Leiden, and prothrombin gene mutation were compared with the rate of detection of one or more gross or histological features of abnormal placentation (impaired placental development or differentiation, maternal vascular underperfusion, fetal vascular underperfusion, chronic inflammation, or intervillous thrombosis). Only 14 of 108 (13.0%) of placentas with documented infarction were associated with a positive maternal thrombophilia result. In contrast, 67 of 108 (62.3%) placentas showed features of abnormal placental development or differentiation and 85 of 108 (78.7%) had evidence of noninfarct-related maternal vascular underperfusion (P<.001). Only four of 108 (3.7%) infarcted placentas had no other pathologic lesions. Our data indicate that gross and histologic features of abnormal placentation associate strongly with placental infarction in comparison with maternal thrombophilia tests. II.Keywords
This publication has 25 references indexed in Scilit:
- The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort StudiesPLOS Medicine, 2010
- First- and Second-Trimester Maternal Serum Markers for Aneuploidy and Adverse Obstetric OutcomesObstetrics & Gynecology, 2010
- Placental size and the prediction of severe early‐onset intrauterine growth restriction in women with low pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 2009
- Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler imagesAmerican Journal of Obstetrics and Gynecology, 2008
- Usefulness of a placental profile in high-risk pregnanciesAmerican Journal of Obstetrics and Gynecology, 2007
- Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteriesPlacenta, 2004
- The frequency and severity of placental findings in women with preeclampsia are gestational age dependentAmerican Journal of Obstetrics and Gynecology, 2003
- A New and Improved Population-Based Canadian Reference for Birth Weight for Gestational AgePediatrics, 2001
- Uterine Doppler Velocimetry and Placental Hypoxic-ischemic Lesion in Pregnancies with Fetal Intrauterine Growth RestrictionPlacenta, 1999
- Increased Frequency of Genetic Thrombophilia in Women with Complications of PregnancyNew England Journal of Medicine, 1999